Skip to content

Media release, July 15, 2010

ALLIANCE FOR A STRONGER FDA APPRECIATES BUT HAS CONCERNS ABOUT THE SENATE APPROPRIATIONS COMMITTEE’S FY 11 MARK FOR FDA

Senate Bill at the President’s Request Level; FDA Still Underfunded for Its Responsibilities

WASHINGTON, D.C., July 15, 2010 – The Alliance for a Stronger FDA today expressed both appreciation and concern about the Senate appropriation committee’s proposed funding for FDA for FY 2011. The committee mark for FDA is for $2.504 billion, a $159 million increase above the FY 10 enacted level and the same amount as the President’s request.

“Over the last few years, the Senate appropriations committee has been a champion of FDA and its need for more funding,” said Wayne Pines, President of the Alliance. “We appreciate the efforts of Chairman Kohl and Ranking Member Brownback and other committee members who have supported FDA funding for FY 11.”

“At the same time, we are concerned that the Senate mark is below the level passed by the House Agriculture/FDA Appropriation Subcommittee,” he continued. “At the House-Senate conference to resolve differences between the bills or in the construction of a continuing resolution, we urge the Senate to accept the House level. FDA can do its job only with appropriate funding.”

The President’s budget request was for an increase of about 6% over FY 10. This is an inflationary increase in a year in which many domestic discretionary programs are likely to be frozen or cut.

“The Alliance will continue to advocate for further increases in funding above both the Senate and House numbers,” said Nancy Bradish Myers, Vice-President of the Alliance and President of Catalyst Healthcare Consulting. “It would be short-sighted to leave our premier public health agency overextended and ill-equipped to carry out its mission. Continuing chronic underfunding of FDA affects our public health, our economy and our national security.”

The Alliance for a Stronger FDA is a coalition of more than 180 consumer, patient, professional and research groups, companies, trade associations, and individuals who support increased appropriated funding for FDA. The Alliance is the only multi-stakeholder group that advocates for increasing resources at FDA to match the agency’s responsibilities.

If you wish to receive more budget analysis, please send an e-mail to info@StrengthenFDA.org.

More information about the Alliance can be found at http://www.StrengthenFDA.org.

#